(Q34392647)

1 August 2017

0 references

Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis (English)

1 reference

1 August 2017

1 reference

Long Wang

1

1 reference

1 August 2017

Jian-wei Zhao

2

1 reference

1 August 2017

Bing Liu

3

1 reference

1 August 2017

Duo Shi

4

1 reference

1 August 2017

Zui Zou

5

1 reference

1 August 2017

Xue-yin Shi

6

1 reference

1 August 2017

publication date

1 October 2012

1 reference

American journal of cardiovascular drugs

1 August 2017

published in

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

335-344

1 reference

1 August 2017

cites work

Essential hypertension

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Angiotensin receptor blockers for management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Olmesartan medoxomil: a review of its use in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Comparative efficacy of valsartan and olmesartan in mild-to-moderate hypertension: results of 24-hour ambulatory blood pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Angiotensin II type 1 receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Comparison of angiotensin II type 1 receptor antagonists in the treatment of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

Angiotensin II antagonists for hypertension: are there differences in efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03261842

21 January 2018

Identifiers

DOI

10.1007/BF03261842

1 reference

Dimensions Publication ID

1 August 2017

1041517171

0 references

Fatcat ID

release_xy7aqzi6engmno7pnncg5vvita

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xy7aqzi6engmno7pnncg5vvita

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference